Ultralife Corporation
ULBI
$5.60
-$0.18-3.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 43.37M | 48.56M | 50.75M | 43.85M | 35.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.37M | 48.56M | 50.75M | 43.85M | 35.69M |
| Cost of Revenue | 33.75M | 36.94M | 37.94M | 33.25M | 27.01M |
| Gross Profit | 9.62M | 11.62M | 12.81M | 10.60M | 8.68M |
| SG&A Expenses | 7.12M | 6.89M | 6.82M | 6.96M | 5.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.73M | 46.15M | 47.16M | 42.63M | 34.93M |
| Operating Income | -357.00K | 2.41M | 3.58M | 1.22M | 761.00K |
| Income Before Tax | -1.75M | 1.11M | 2.45M | 495.00K | 353.00K |
| Income Tax Expenses | -504.00K | 243.00K | 567.00K | 262.00K | 74.00K |
| Earnings from Continuing Operations | -1.25M | 870.00K | 1.88M | 233.00K | 279.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 27.00K | 9.00K | -14.00K | -39.00K | -21.00K |
| Net Income | -1.22M | 879.00K | 1.87M | 194.00K | 258.00K |
| EBIT | -357.00K | 2.41M | 3.58M | 1.22M | 761.00K |
| EBITDA | 1.06M | 3.83M | 4.94M | 2.40M | 1.76M |
| EPS Basic | -0.07 | 0.05 | 0.11 | 0.01 | 0.02 |
| Normalized Basic EPS | -0.04 | 0.05 | 0.10 | 0.01 | 0.02 |
| EPS Diluted | -0.07 | 0.05 | 0.11 | 0.01 | 0.02 |
| Normalized Diluted EPS | -0.04 | 0.05 | 0.10 | 0.01 | 0.02 |
| Average Basic Shares Outstanding | 16.65M | 16.64M | 16.63M | 16.63M | 16.63M |
| Average Diluted Shares Outstanding | 16.65M | 16.66M | 16.68M | 16.76M | 16.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |